Product Code: A03361
The global interventional oncology market size is expected to reach up to $3,791.50 million by 2030, surging from $2,131.30 million in 2021, at a noteworthy CAGR of 6.5%.
Interventional oncology (IO) is an emerging specialty that focuses on using image-guided procedures (diagnostics/surgeries) to improve cancer therapy. Along with surgery, medication, and radiation, IO is currently the fourth pillar of modern oncology care. Due to an increase in cancer cases among people worldwide, the interventional oncology market is expected to accelerate its expansion over the forecast period. Cancer is one of the fastest rising health problems in the world, impacting people of all ages, from infants to the elderly. Breast cancer and throat cancer are two of the most common types of cancer in people. The need for technologically improved cancer management therapy has expanded in tandem with the rise in the number of cancer patients. This aspect is predicted to contribute to the market's positive expansion in the following years. However, because interventional oncology therapy is a relatively new branch of treatment, its market penetration is low, and few people are aware of it.
The global interventional oncology market is segmented on the basis of product type, cancer type, and end user. On basis of product type, the market has been divided into embolization devices, ablation devices, and support devices. Based on cancer type, the market has been divided into liver cancer, lung cancer, bone metastasis, kidney cancer, breast cancer, prostate cancer, and other cancers. Based on end-user, the market has been categorized into hospitals, ambulatory surgery centers, and research & academic institutes. By region, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the leading interventional oncology market players are Medtronic, Boston Scientific, BD, Terumo, Merit Medical, AngioDynamics, J&J, Teleflex, Cook Medical, and HealthTronics.
KEY MARKET SEGMENTS
By Product Type
- Embolization Devices
- Ablation Devices
- Support Devices
By Cancer Type
- Liver Cancer
- Lung Cancer
- Bone Metastasis
- Kidney Cancer
- Breast Cancer
- Prostate Cancer
- Other Cancers
By End User
- Hospitals
- Ambulatory Surgery Centers
- Research & Academic Institutes
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- Saudi Arab Emirate
- South Africa
- Rest of LAMEA
- Key Players
- Medtronic
- Boston Scientific
- BD
- Terumo
- Merit Medical
- AngioDynamics
- J&J
- Teleflex
- Cook Medical
- HealthTronics.
- Key Market Segments
By Product
- Ablation
- Radiofrequency Ablation Devices
- Microwave Ablation Devices
- Cryoablation Devices
- Others
- Particle Embolization
- Radioembolic agents
- Drug-Eluting Beads
- Others
- Support Devices
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Taiwan
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Turkey
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Alpinion Medical Systems Co. Ltd.
- AngioDynamics
- Boston Scientific Corporation
- Hologic, Inc.
- Medtronic Plc.
- Merit Medical
- Profound Medical
- Siemens Healthineers
- Teleflex Incorporated
- Terumo Corporation
TABLE OF CONTENTS
CHAPTER 1:INTRODUCTION
- 1.1.Report description
- 1.2.Key market segments
- 1.3.Key benefits to the stakeholders
- 1.4.Research Methodology
- 1.4.1.Secondary research
- 1.4.2.Primary research
- 1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.Key findings of the study
- 2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
- 3.1.Market definition and scope
- 3.2.Key findings
- 3.2.1.Top investment pockets
- 3.3.Porter's five forces analysis
- 3.4.Top player positioning
- 3.5.Market dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis on the market
- 3.7.Value Chain Analysis
- 3.8.Key Regulation Analysis
- 3.9.Market Share Analysis
- 3.10.Regulatory Guidelines
CHAPTER 4: INTERVENTIONAL ONCOLOGY MARKET, BY PRODUCT TYPE
- 4.1 Overview
- 4.1.1 Market size and forecast
- 4.2 Embolization Devices
- 4.2.1 Key market trends, growth factors and opportunities
- 4.2.2 Market size and forecast, by region
- 4.2.3 Market analysis by country
- 4.3 Ablation Devices
- 4.3.1 Key market trends, growth factors and opportunities
- 4.3.2 Market size and forecast, by region
- 4.3.3 Market analysis by country
- 4.4 Support Devices
- 4.4.1 Key market trends, growth factors and opportunities
- 4.4.2 Market size and forecast, by region
- 4.4.3 Market analysis by country
CHAPTER 5: INTERVENTIONAL ONCOLOGY MARKET, BY CANCER TYPE
- 5.1 Overview
- 5.1.1 Market size and forecast
- 5.2 Liver Cancer
- 5.2.1 Key market trends, growth factors and opportunities
- 5.2.2 Market size and forecast, by region
- 5.2.3 Market analysis by country
- 5.3 Lung Cancer
- 5.3.1 Key market trends, growth factors and opportunities
- 5.3.2 Market size and forecast, by region
- 5.3.3 Market analysis by country
- 5.4 Breast Cancer
- 5.4.1 Key market trends, growth factors and opportunities
- 5.4.2 Market size and forecast, by region
- 5.4.3 Market analysis by country
- 5.5 Prostate Cancer
- 5.5.1 Key market trends, growth factors and opportunities
- 5.5.2 Market size and forecast, by region
- 5.5.3 Market analysis by country
- 5.6 Kidney Cancer
- 5.6.1 Key market trends, growth factors and opportunities
- 5.6.2 Market size and forecast, by region
- 5.6.3 Market analysis by country
- 5.7 Bone Metastasis
- 5.7.1 Key market trends, growth factors and opportunities
- 5.7.2 Market size and forecast, by region
- 5.7.3 Market analysis by country
- 5.8 Other Cancers
- 5.8.1 Key market trends, growth factors and opportunities
- 5.8.2 Market size and forecast, by region
- 5.8.3 Market analysis by country
CHAPTER 6: INTERVENTIONAL ONCOLOGY MARKET, BY END USER
- 6.1 Overview
- 6.1.1 Market size and forecast
- 6.2 Hospitals
- 6.2.1 Key market trends, growth factors and opportunities
- 6.2.2 Market size and forecast, by region
- 6.2.3 Market analysis by country
- 6.3 Ambulatory Surgery Centers
- 6.3.1 Key market trends, growth factors and opportunities
- 6.3.2 Market size and forecast, by region
- 6.3.3 Market analysis by country
- 6.4 Research and Academic Institutes
- 6.4.1 Key market trends, growth factors and opportunities
- 6.4.2 Market size and forecast, by region
- 6.4.3 Market analysis by country
CHAPTER 7: INTERVENTIONAL ONCOLOGY MARKET, BY REGION
- 7.1 Overview
- 7.1.1 Market size and forecast
- 7.2 North America
- 7.2.1 Key trends and opportunities
- 7.2.2 North America Market size and forecast, by Product Type
- 7.2.3 North America Market size and forecast, by Cancer Type
- 7.2.4 North America Market size and forecast, by End User
- 7.2.5 North America Market size and forecast, by country
- 7.2.5.1 U.S.
- 7.2.5.1.1 Market size and forecast, by Product Type
- 7.2.5.1.2 Market size and forecast, by Cancer Type
- 7.2.5.1.3 Market size and forecast, by End User
- 7.2.5.2 Canada
- 7.2.5.2.1 Market size and forecast, by Product Type
- 7.2.5.2.2 Market size and forecast, by Cancer Type
- 7.2.5.2.3 Market size and forecast, by End User
- 7.2.5.3 Mexico
- 7.2.5.3.1 Market size and forecast, by Product Type
- 7.2.5.3.2 Market size and forecast, by Cancer Type
- 7.2.5.3.3 Market size and forecast, by End User
- 7.3 Europe
- 7.3.1 Key trends and opportunities
- 7.3.2 Europe Market size and forecast, by Product Type
- 7.3.3 Europe Market size and forecast, by Cancer Type
- 7.3.4 Europe Market size and forecast, by End User
- 7.3.5 Europe Market size and forecast, by country
- 7.3.5.1 Germany
- 7.3.5.1.1 Market size and forecast, by Product Type
- 7.3.5.1.2 Market size and forecast, by Cancer Type
- 7.3.5.1.3 Market size and forecast, by End User
- 7.3.5.2 U.K.
- 7.3.5.2.1 Market size and forecast, by Product Type
- 7.3.5.2.2 Market size and forecast, by Cancer Type
- 7.3.5.2.3 Market size and forecast, by End User
- 7.3.5.3 France
- 7.3.5.3.1 Market size and forecast, by Product Type
- 7.3.5.3.2 Market size and forecast, by Cancer Type
- 7.3.5.3.3 Market size and forecast, by End User
- 7.3.5.4 Spain
- 7.3.5.4.1 Market size and forecast, by Product Type
- 7.3.5.4.2 Market size and forecast, by Cancer Type
- 7.3.5.4.3 Market size and forecast, by End User
- 7.3.5.5 Italy
- 7.3.5.5.1 Market size and forecast, by Product Type
- 7.3.5.5.2 Market size and forecast, by Cancer Type
- 7.3.5.5.3 Market size and forecast, by End User
- 7.3.5.6 Rest of Europe
- 7.3.5.6.1 Market size and forecast, by Product Type
- 7.3.5.6.2 Market size and forecast, by Cancer Type
- 7.3.5.6.3 Market size and forecast, by End User
- 7.4 Asia-Pacific
- 7.4.1 Key trends and opportunities
- 7.4.2 Asia-Pacific Market size and forecast, by Product Type
- 7.4.3 Asia-Pacific Market size and forecast, by Cancer Type
- 7.4.4 Asia-Pacific Market size and forecast, by End User
- 7.4.5 Asia-Pacific Market size and forecast, by country
- 7.4.5.1 China
- 7.4.5.1.1 Market size and forecast, by Product Type
- 7.4.5.1.2 Market size and forecast, by Cancer Type
- 7.4.5.1.3 Market size and forecast, by End User
- 7.4.5.2 Japan
- 7.4.5.2.1 Market size and forecast, by Product Type
- 7.4.5.2.2 Market size and forecast, by Cancer Type
- 7.4.5.2.3 Market size and forecast, by End User
- 7.4.5.3 India
- 7.4.5.3.1 Market size and forecast, by Product Type
- 7.4.5.3.2 Market size and forecast, by Cancer Type
- 7.4.5.3.3 Market size and forecast, by End User
- 7.4.5.4 South Korea
- 7.4.5.4.1 Market size and forecast, by Product Type
- 7.4.5.4.2 Market size and forecast, by Cancer Type
- 7.4.5.4.3 Market size and forecast, by End User
- 7.4.5.5 Australia
- 7.4.5.5.1 Market size and forecast, by Product Type
- 7.4.5.5.2 Market size and forecast, by Cancer Type
- 7.4.5.5.3 Market size and forecast, by End User
- 7.4.5.6 Rest Of Asia Pacific
- 7.4.5.6.1 Market size and forecast, by Product Type
- 7.4.5.6.2 Market size and forecast, by Cancer Type
- 7.4.5.6.3 Market size and forecast, by End User
- 7.5 LAMEA
- 7.5.1 Key trends and opportunities
- 7.5.2 LAMEA Market size and forecast, by Product Type
- 7.5.3 LAMEA Market size and forecast, by Cancer Type
- 7.5.4 LAMEA Market size and forecast, by End User
- 7.5.5 LAMEA Market size and forecast, by country
- 7.5.5.1 Brazil
- 7.5.5.1.1 Market size and forecast, by Product Type
- 7.5.5.1.2 Market size and forecast, by Cancer Type
- 7.5.5.1.3 Market size and forecast, by End User
- 7.5.5.2 Saudi Arabia
- 7.5.5.2.1 Market size and forecast, by Product Type
- 7.5.5.2.2 Market size and forecast, by Cancer Type
- 7.5.5.2.3 Market size and forecast, by End User
- 7.5.5.3 South Africa
- 7.5.5.3.1 Market size and forecast, by Product Type
- 7.5.5.3.2 Market size and forecast, by Cancer Type
- 7.5.5.3.3 Market size and forecast, by End User
- 7.5.5.4 Rest of LAMEA
- 7.5.5.4.1 Market size and forecast, by Product Type
- 7.5.5.4.2 Market size and forecast, by Cancer Type
- 7.5.5.4.3 Market size and forecast, by End User
CHAPTER 8: COMPANY LANDSCAPE
- 8.1. Introduction
- 8.2. Top winning strategies
- 8.3. Product Mapping of Top 10 Player
- 8.4. Competitive Dashboard
- 8.5. Competitive Heatmap
- 8.6. Key developments
CHAPTER 9: COMPANY PROFILES
- 9.1 Medtronic, Inc.
- 9.1.1 Company overview
- 9.1.2 Company snapshot
- 9.1.3 Operating business segments
- 9.1.4 Product portfolio
- 9.1.5 Business performance
- 9.1.6 Key strategic moves and developments
- 9.2 Boston Scientific Corporation
- 9.2.1 Company overview
- 9.2.2 Company snapshot
- 9.2.3 Operating business segments
- 9.2.4 Product portfolio
- 9.2.5 Business performance
- 9.2.6 Key strategic moves and developments
- 9.3 BD
- 9.3.1 Company overview
- 9.3.2 Company snapshot
- 9.3.3 Operating business segments
- 9.3.4 Product portfolio
- 9.3.5 Business performance
- 9.3.6 Key strategic moves and developments
- 9.4 Terumo Corporation
- 9.4.1 Company overview
- 9.4.2 Company snapshot
- 9.4.3 Operating business segments
- 9.4.4 Product portfolio
- 9.4.5 Business performance
- 9.4.6 Key strategic moves and developments
- 9.5 Merit Medical
- 9.5.1 Company overview
- 9.5.2 Company snapshot
- 9.5.3 Operating business segments
- 9.5.4 Product portfolio
- 9.5.5 Business performance
- 9.5.6 Key strategic moves and developments
- 9.6 AngioDynamics
- 9.6.1 Company overview
- 9.6.2 Company snapshot
- 9.6.3 Operating business segments
- 9.6.4 Product portfolio
- 9.6.5 Business performance
- 9.6.6 Key strategic moves and developments
- 9.7 Johnson & Johnson
- 9.7.1 Company overview
- 9.7.2 Company snapshot
- 9.7.3 Operating business segments
- 9.7.4 Product portfolio
- 9.7.5 Business performance
- 9.7.6 Key strategic moves and developments
- 9.8 Teleflex Incorporated
- 9.8.1 Company overview
- 9.8.2 Company snapshot
- 9.8.3 Operating business segments
- 9.8.4 Product portfolio
- 9.8.5 Business performance
- 9.8.6 Key strategic moves and developments
- 9.9 Cook Group
- 9.9.1 Company overview
- 9.9.2 Company snapshot
- 9.9.3 Operating business segments
- 9.9.4 Product portfolio
- 9.9.5 Business performance
- 9.9.6 Key strategic moves and developments
- 9.10 HealthTronics, Inc.
- 9.10.1 Company overview
- 9.10.2 Company snapshot
- 9.10.3 Operating business segments
- 9.10.4 Product portfolio
- 9.10.5 Business performance
- 9.10.6 Key strategic moves and developments